Showing results (791-800 of 6,995) with videos related to
Sort By:
Pageof 700
Cancer Science|October 27, 2004
Identification of a mouse cytoskeleton-associated protein, CKAP2, with microtubule-stabilizing propertiesYi Jin, Yoshiki Murakumo, Kaoru Ueno, et al.Cancer Science|May 11, 2004
The expressions of p21 and pRB may be good indicators for the sensitivity of esophageal squamous cell cancers to CPT-11: Cell proliferation activity correlates with the effect of CPT-11Yasuaki Nakajima, Satoshi Miyake, Koji Tanaka, et al.Cancer Science|August 10, 2004
Dominant-negative Stat5 inhibits growth and induces apoptosis in T47D-derived tumors in nude miceHiroko Yamashita, Mariko Nishio, Yoshitaka Fujii, et al.Cancer Science|August 10, 2004
Involvement of cell cycle regulatory proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellular carcinoma cell linesJidong Cheng, Hiroyasu Imanishi, Weidong Liu, et al.Cancer Science|August 10, 2004
Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancerIkuo Sekine, Kazumasa Noda, Fumihiro Oshita, et al.Cancer Science|July 13, 2004
Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude miceKazuyoshi Yanagihara, Hiromi Tanaka, Misato Takigahira, et al.Cancer Science|June 9, 2004
Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genesNobuyuki Yoshida, Yoko Omoto, Akio Inoue, et al.Cancer Science|June 9, 2004
Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liverMotonobu Furukawa, Masuhiro Nishimura, Daisuke Ogino, et al.Cancer Science|December 15, 2004
Skp2 overexpression is a p27Kip1-independent predictor of poor prognosis in patients with biliary tract cancersTakahiro Sanada, Sana Yokoi, Shigeki Arii, et al.Cancer Science|December 15, 2004
Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib ("Iressa")-sensitive and resistant xenograft modelsFumiko Taguchi, Yasuhiro Koh, Fumiaki Koizumi, et al.Pageof 700